Biovie Inc.股价上涨25.36% 市值涨667.48万美元

市场透视10-22

北京时间2024年10月22日21时31分，Biovie Inc.（BIVI.us）股票出现波动，股价急速拉升25.36%。截至发稿，该股报3.30美元/股，成交量545.754万股，换手率68.36%，振幅14.45%。最近的财报数据显示，该股实现营业收入0.00美元，净利润-32.12百万美元，每股收益-7.30美元，毛利-229377.00美元，市盈率-0.45倍。机构评级方面，在所有1家...

网页链接

免责声明：本文观点仅代表作者个人观点，不构成本平台的投资建议，本平台不对文章信息准确性、完整性和及时性做出任何保证，亦不对因使用或信赖文章信息引发的任何损失承担责任。

精彩评论

我们需要你的真知灼见来填补这片空白

发表看法

{"i18n":{"language":"zh_CN"},"isChannel":false,"data":{"share":"https://www.laohu8.com/m/news/2477332730?lang=zh_CN&edition=full","thumbnail":"","is_english":false,"pubTime":"2024-10-22 21:31","share_image_url":"https://static.laohu8.com/9a95c1376e76363c1401fee7d3717173","id":"2477332730","market":"us","top_or_hot":-1,"title":"Biovie Inc.股价上涨25.36% 市值涨667.48万美元","media":"市场透视","content":"<div>\n<p>北京时间2024年10月22日21时31分，Biovie Inc.（BIVI.us）股票出现波动，股价急速拉升25.36%。截至发稿，该股报3.30美元/股，成交量545.754万股，换手率68.36%，振幅14.45%。最近的财报数据显示，该股实现营业收入0.00美元，净利润-32.12百万美元，每股收益-7.30美元，毛利-229377.00美元，市盈率-0.45倍。机构评级方面，在所有1家...</p>\n\n<a href=\"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024102221315195bb6c4c&s=b\">网页链接</a>\n\n</div>\n","source":"tencent","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Biovie Inc.股价上涨25.36% 市值涨667.48万美元</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nBiovie Inc.股价上涨25.36% 市值涨667.48万美元\n</h2>\n\n<h4 class=\"meta\">\n\n\n2024-10-22 21:31 北京时间&nbsp;&nbsp;&nbsp;<a href=http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024102221315195bb6c4c&s=b><strong>市场透视</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>北京时间2024年10月22日21时31分，Biovie Inc.（BIVI.us）股票出现波动，股价急速拉升25.36%。截至发稿，该股报3.30美元/股，成交量545.754万股，换手率68.36%，振幅14.45%。最近的财报数据显示，该股实现营业收入0.00美元，净利润-32.12百万美元，每股收益-7.30美元，毛利-229377.00美元，市盈率-0.45倍。机构评级方面，在所有1家...</p>\n\n<a href=\"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024102221315195bb6c4c&s=b\">网页链接</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK4139","symbol_name":"生物科技","start_time":0,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024102221315195bb6c4c&s=b","article_id":"2477332730","we_media_id":null,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024102221315195bb6c4c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"url":"https://stock-news.laohu8.com/highlight/detail?id=2477332730","pubTimestamp":1729603911,"columns":[],"sourceInfo":{"source_id":"tencent","name":"腾讯"},"weMediaInfo":null,"summary":"北京时间2024年10月22日21时31分，Biovie Inc.股票出现波动，股价急速拉升25.36%。截至发稿，该股报3.30美元/股，成交量545.754万股，换手率68.36%，振幅14.45%。Biovie Inc.股票所在的生物技术行业中，整体跌幅为0.29%。其相关个股中，Ensysce Biosciences, Inc.、Genprex, Inc.、Tc Biopharm  Plc涨幅较大，Genprex, Inc.、Tc Biopharm  Plc、Ensysce Biosciences, Inc.较为活跃，换手率分别为1891.88%、1134.16%、1087.94%，振幅较大的相关个股有Psyence Biomedical Ltd C/Wts 25/01/2029、Ensysce Biosciences, Inc.、Genprex, Inc.，振幅分别为52.51%、43.69%、25.83%。","collect":0,"end_time":0,"defaultTopTitle":"qq.com","property":[],"viewcount":null,"language":"zh","relate_stocks":{"BK4139":"生物科技","BIVI":"BioVie Inc"},"translate_title":"Biovie Inc. 's stock rose 25.36%, its market value rose by $6.6748 million","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"BIVI":1},"content_text":"北京时间2024年10月22日21时31分，Biovie Inc.（BIVI.us）股票出现波动，股价急速拉升25.36%。截至发稿，该股报3.30美元/股，成交量545.754万股，换手率68.36%，振幅14.45%。最近的财报数据显示，该股实现营业收入0.00美元，净利润-32.12百万美元，每股收益-7.30美元，毛利-229377.00美元，市盈率-0.45倍。机构评级方面，在所有1家参与评级的机构中，100%的券商给予买入建议，无券商给予持有、卖出建议。Biovie Inc.股票所在的生物技术行业中，整体跌幅为0.29%。其相关个股中，Ensysce Biosciences, Inc.、Genprex, Inc.、Tc Biopharm (Holdings) Plc涨幅较大，Genprex, Inc.、Tc Biopharm (Holdings) Plc、Ensysce Biosciences, Inc.较为活跃，换手率分别为1891.88%、1134.16%、1087.94%，振幅较大的相关个股有Psyence Biomedical Ltd C/Wts 25/01/2029(To Pur Com)、Ensysce Biosciences, Inc.、Genprex, Inc.，振幅分别为52.51%、43.69%、25.83%。Biovie Inc.公司简介：BioVie Inc 是一家临床阶段公司，开发创新药物疗法来治疗慢性衰弱性疾病，包括肝病、神经系统和神经退行性疾病以及某些癌症。 该公司正在进行一项潜在关键的三期随机、双盲、安慰剂对照、平行组、多中心研究，以评估 NE3107 对患有轻度至中度阿尔茨海默病的患者的疗效。 BIV201有可能改善数千名因肝炎、非酒精性脂肪性肝炎和酗酒而患有危及生命的肝硬化并发症的患者的健康。（以上内容为腾讯自选股基于公开消息，由程序或算法智能生成，仅作为用户看盘参考，不作为投资建议或交易依据。股市有风险，请谨慎决策。）","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"","news_rank":0,"symbols":[],"gpt_button":0},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.29.3","shortVersion":"4.29.3","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2477332730"}